Next Article in Journal
Gypenoside XLIX Ameliorate High-Fat Diet-Induced Atherosclerosis via Regulating Intestinal Microbiota, Alleviating Inflammatory Response and Restraining Oxidative Stress in ApoE−/− Mice
Next Article in Special Issue
Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1–4
Previous Article in Journal
Glucoraphanin Triggers Rapid Antidepressant Responses in a Rat Model of Beta Amyloid-Induced Depressive-like Behaviour
Previous Article in Special Issue
Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(9), 1055; https://doi.org/10.3390/ph15091055
Action Date Notes Link
article html file updated 10 September 2025 22:33 CEST Update https://www.mdpi.com/1424-8247/15/9/1055/html
article html file updated 22 August 2025 02:53 CEST Update -
article html file updated 28 February 2023 10:51 CET Update -
article html file updated 26 August 2022 11:01 CEST Original file -
article supplementary file uploaded. 26 August 2022 11:00 CEST - https://www.mdpi.com/1424-8247/15/9/1055#supplementary
article pdf uploaded. 26 August 2022 11:00 CEST Version of Record https://www.mdpi.com/1424-8247/15/9/1055/pdf
article xml uploaded. 26 August 2022 11:00 CEST Update https://www.mdpi.com/1424-8247/15/9/1055/xml
article xml file uploaded 26 August 2022 11:00 CEST Original file -
Back to TopTop